Literature DB >> 19871490

PLASMA PROTEIN PRODUCTION INFLUENCED BY AMINO ACID MIXTURES AND LACK OF ESSENTIAL AMINO ACIDS : A DEFICIENCY STATE RELATED TO UNKNOWN FACTORS.

S C Madden1, F W Anderson, J C Donovan, G H Whipple.   

Abstract

When blood plasma proteins are depleted by bleeding with return of red cells suspended in saline (plasmapheresis) it is possible to bring dogs to a steady state of hypoproteinemia and a constant level of plasma protein production if the diet nitrogen intake is controlled and limited. Such dogs are outwardly normal but have a lowered resistance to infection and intoxication and probably to vitamin deficiency. When the diet nitrogen is provided by certain mixtures of the ten growth essential amino acids plus glycine, given intravenously at a rapid rate, plasma protein production is good. The same mixture absorbed subcutaneously at a slower rate may be slightly better utilized. Fed orally the same mixture is better utilized and associated with a lower urinary nitrogen excretion. An ample amino acid mixture for the daily intake of a 10 kilo dog may contain in grams dl-threonine 1.4, dl-valine 3, dl-leucine 3, dl-isoleucine 2, l(+)-lysine.HCl.H(2)O 2.2, dl-tryptophane 0.3, dl-phenylalanine 2, dl-methionine 1.2, l(+)-histidine.HCl.H(2)O 1, l(+)-arginine.HCl 1, and glycine 2. Half this quantity is inadequate and not improved by addition of a mixture of alanine, serine, norleucine, proline, hydroxyproline, and tyrosine totalling 1.4 gm. Aspartic acid appears to induce vomiting when added to a mixture of amino acids. The same response has been reported for glutamic acid (8). Omission from the intake of leucine or of leucine and isoleucine results in negative nitrogen balance and rapid weight loss but plasma protein production may be temporarily maintained. It is possible that leucine may be captured from red blood cell destruction. Tryptophane deficiency causes an abrupt decline in plasma protein production. No decline occurred during 2 weeks of histidine deficiency but the urinary nitrogen increased to negative balance. Plasma protein production may be impaired during conditions of dietary deficiency not related to the protein or amino acid intake. Skin lesions and liver function impairment are described. Unidentified factors present in liver and yeast appear to be involved.

Entities:  

Year:  1945        PMID: 19871490      PMCID: PMC2135543          DOI: 10.1084/jem.82.2.77

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  THE SIGNIFICANCE OF THE AMINO ACIDS IN CANINE NUTRITION.

Authors:  W C Rose; E E Rice
Journal:  Science       Date:  1939-08-25       Impact factor: 47.728

2.  ECK FISTULA LIVER SUBNORMAL IN PRODUCING HEMOGLOBIN AND PLASMA PROTEINS ON DIETS RICH IN LIVER AND IRON.

Authors:  G H Whipple; F S Robscheit-Robbins; W B Hawkins
Journal:  J Exp Med       Date:  1945-02-01       Impact factor: 14.307

3.  TOLERANCE TO AMINO ACID MIXTURES AND CASEIN DIGESTS GIVEN INTRAVENOUSLY : GLUTAMIC ACID RESPONSIBLE FOR REACTIONS.

Authors:  S C Madden; R R Woods; F W Shull; J H Remington; G H Whipple
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

4.  TEN AMINO ACIDS ESSENTIAL FOR PLASMA PROTEIN PRODUCTION EFFECTIVE ORALLY OR INTRAVENOUSLY.

Authors:  S C Madden; J R Carter; A A Kattus; L L Miller; G H Whipple
Journal:  J Exp Med       Date:  1943-03-01       Impact factor: 14.307

5.  AMINO ACID MIXTURES EFFECTIVE PARENTERALLY FOR LONG CONTINUED PLASMA PROTEIN PRODUCTION. CASEIN DIGESTS COMPARED.

Authors:  S C Madden; R R Woods; F W Shull; G H Whipple
Journal:  J Exp Med       Date:  1944-06-01       Impact factor: 14.307

6.  BLOOD PLASMA PROTEIN REGENERATION AS INFLUENCED BY INFECTION, DIGESTIVE DISTURBANCES, THYROID, AND FOOD PROTEINS : A DEFICIENCY STATE RELATED TO PROTEIN DEPLETION.

Authors:  S C Madden; P M Winslow; J W Rowland; G H Whipple
Journal:  J Exp Med       Date:  1937-02-28       Impact factor: 14.307

7.  BLOOD PLASMA PROTEIN GIVEN BY VEIN UTILIZED IN BODY METABOLISM : II. A DYNAMIC EQUILIBRIUM BETWEEN PLASMA AND TISSUE PROTEINS.

Authors:  R L Holman; E B Mahoney; G H Whipple
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

8.  LIVER FUNCTION AND BLOOD PLASMA PROTEIN FORMATION : NORMAL AND ECK FISTULA DOGS.

Authors:  R E Knutti; C C Erickson; S C Madden; P E Rekers; G H Whipple
Journal:  J Exp Med       Date:  1937-02-28       Impact factor: 14.307

  8 in total
  7 in total

1.  [METABOLISM IN INTRAVENOUS ADMINISTRATION OF NUTRITIONAL SOLUTIONS, WITH SPECIAL REFERENCE TO SYNTHETICALLY COMPOSED AMINO ACID SOLUTIONS].

Authors:  H W BANSI; P JUERGENS; G MUELLER; M ROSTIN
Journal:  Klin Wochenschr       Date:  1964-04-01

2.  Iron accumulation in tissues of magnesium-deficient rats with dietary iron overload.

Authors:  M Kimura; K Yokoi
Journal:  Biol Trace Elem Res       Date:  1996-02       Impact factor: 3.738

Review 3.  Elemental diets.

Authors:  R I Russel
Journal:  Gut       Date:  1975-01       Impact factor: 23.059

4.  PLASMA PROTEIN AND HEMOGLOBIN PRODUCTION : DELETION OF INDIVIDUAL AMINO ACIDS FROM GROWTH MIXTURE OF TEN ESSENTIAL AMINO ACIDS. SIGNIFICANT CHANGES IN URINARY NITROGEN.

Authors:  F S Robscheit-Robbins; L L Miller; G H Whipple
Journal:  J Exp Med       Date:  1947-02-28       Impact factor: 14.307

5.  Bile salt metabolism as influenced by pure amino acids and casein digests.

Authors:  W B HAWKINS; P C HANSON
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

6.  PLASMA PROTEIN PRODUCTION AS INFLUENCED BY PARENTERAL PROTEIN DIGESTS, VERY HIGH PROTEIN FEEDING, AND RED BLOOD CELL CATABOLISM.

Authors:  S C Madden; A A Kattus; J R Carter; L L Miller; G H Whipple
Journal:  J Exp Med       Date:  1945-09-01       Impact factor: 14.307

7.  The dominant role of the liver in plasma protein synthesis; a direct study of the isolated perfused rat liver with the aid of lysine-epsilon-C14.

Authors:  L L MILLER; C G BLY; M L WATSON; W F BALE
Journal:  J Exp Med       Date:  1951-11       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.